NAGE

Niagen Bioscience Stock Analysis

AI Rating

Good
  • Quality8/10
  • Growth↑ 9/10
  • Momentum↓ 1/10
Niagen Bioscience sales and earnings growth
NAGE Growth
Great
  • Revenue Y/Y↑ 36.04%
  • EPS Y/Y↑ 2600.00%
  • FCF Y/Y↑ 418.33%
Niagen Bioscience gross and profit margin trends
NAGE Profitability
Good
  • Gross margin ↑ 63.90%
  • EPS margin↑ 16.40%
  • ROIC↑ 203.70%
Niagen Bioscience net debt vs free cash flow
NAGE Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Niagen Bioscience stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗